CVS Health Corp (CVS) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

CVS Health Corporation provides health solutions in the United States.

Total Revenue Chart for CVS Health Corp

CVS Health Corp (CVS) revenue for FY2025 was USD 402.1B, a 7.8% change from FY2024. CVS Health Corp's revenue grew from USD 4.8B in 1985 to USD 402.1B in 2025 (8320.4% over 40 years). Earnings per share grew from USD 0.92 in 2000 to USD 1.39 in 2025 (52.0%). Revenue compound annual growth rate: 5-year CAGR of 8.4%, 10-year CAGR of 10.1%, 20-year CAGR of 12.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$123.06B
Implied Share Price
$96.22
Enterprise Value
$199.79B
Revenue (TTM)
$412.64B
EBITDA
$16.68B
Profit Margin
1.18%
Trailing P/E
26.15
Forward P/E
14.16
Price/Book (MRQ)
1.72
Price/Sales (TTM)
0.30
EV/EBITDA
17.95
EV/Revenue
0.49
Dividend Yield
2.68%
Book Value
$62.37
Free Cash Flow (FY2025)
$7.81B
Free Cash Flow Yield
6.34%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.